HM
HealthCor Management Portfolio holdings
AUM
$109M
This Quarter Return
+4.96%
1 Year Return
+11.46%
3 Year Return
+50.01%
5 Year Return
+144.68%
10 Year Return
–
AUM
$1.76B
AUM Growth
+$1.76B
(+8.9%)
Cap. Flow
+$107M
Cap. Flow
% of AUM
6.09%
Top 10 Holdings %
Top 10 Hldgs %
59.44%
Holding
77
New
20
Increased
16
Reduced
11
Closed
25
Top Buys
| 1 |
HCA Healthcare
HCA
|
$122M |
| 2 |
Edwards Lifesciences
EW
|
$121M |
| 3 |
AKRX
Akorn, Inc.
AKRX
|
$75.3M |
| 4 |
CVRS
CORINDUS VASCULAR ROBOTICS, INC
CVRS
|
$70.1M |
| 5 |
RAD
Rite Aid Corporation
RAD
|
$56.3M |
Top Sells
| 1 |
Viatris
VTRS
|
$68M |
| 2 |
Teva Pharmaceuticals
TEVA
|
$64.2M |
| 3 |
Biogen
BIIB
|
$64.1M |
| 4 |
Jazz Pharmaceuticals
JAZZ
|
$56.2M |
| 5 |
Boston Scientific
BSX
|
$42.4M |
Sector Composition
| 1 | Healthcare | 68.05% |
| 2 | Financials | 5.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Edwards Lifesciences
EW
$47.8B
| $157M | 7.89% | 1,100,000 +850,000 | +340% | +$121M |
|
|
2
HCA Healthcare
HCA
$94.5B
| $122M | 6.17% | +1,350,000 | New | +$122M |
|
|
MNK
3
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $115M | 5.78% | 975,000 +175,000 | +22% | +$20.6M |
|
|
HZNP
4
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $111M | 5.6% | 3,200,000 -800,000 | -20% | -$27.8M |
|
|
AET
5
DELISTED
Aetna Inc
AET
| $105M | 5.29% | 825,000 +125,000 | +18% | +$15.9M |
|
|
RAD
6
DELISTED
Rite Aid Corporation
RAD
| $100M | 5.05% | 12,000,000 +6,737,100 | +128% | +$56.3M |
|
7
Brookdale Senior Living
BKD
$1.83B
| $98.9M | 4.98% | 2,850,000 +900,000 | +46% | +$31.2M |
|
|
BCR
8
DELISTED
CR Bard Inc.
BCR
| $81.1M | 4.08% | 475,000 +275,000 | +138% | +$46.9M |
|
|
MDVN
9
DELISTED
MEDIVATION, INC.
MDVN
| $79.9M | 4.02% | 700,000 +325,000 | +87% | +$37.1M |
|
|
AKRX
10
DELISTED
Akorn, Inc.
AKRX
| $75.3M | 3.79% | +1,725,000 | New | +$75.3M |
|
|
CVRS
11
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
| $70.1M | 3.53% | +19,981,655 | New | +$70.1M |
|
12
Vertex Pharmaceuticals
VRTX
$100B
| $55.6M | 2.8% | 450,000 +175,000 | +64% | +$21.6M |
|
13
Cigna
CI
$80.3B
| $52.7M | 2.65% | 325,000 +291,841 | +880% | +$47.3M |
|
14
Danaher
DHR
$147B
| $51.4M | 2.59% | 600,000 +534,900 | +822% | +$45.8M |
|
15
Labcorp
LH
$23.1B
| $42.4M | 2.14% | 350,000 -325,000 | -48% | -$39.4M |
|
|
ALR
16
DELISTED
Alere Inc
ALR
| $38.2M | 1.93% | 725,000 -74,900 | -9% | -$3.95M |
|
|
ABCO
17
DELISTED
Advisory Board Co/The
ABCO
| $36.9M | 1.86% | +675,000 | New | +$36.9M |
|
18
Acadia Pharmaceuticals
ACAD
$4.38B
| $34.6M | 1.74% | 825,000 +100,000 | +14% | +$4.19M |
|
|
RLYP
19
DELISTED
RELYPSA INC COM
RLYP
| $27.2M | 1.37% | 822,892 -52,108 | -6% | -$1.72M |
|
20
Integra LifeSciences
IART
$1.18B
| $26M | 1.31% | 386,200 +211,200 | +121% | +$14.2M |
|
|
IPXL
21
DELISTED
Impax Laboratories, Inc.
IPXL
| $25.3M | 1.27% | +550,000 | New | +$25.3M |
|
22
Perrigo
PRGO
$3.27B
| $24.9M | 1.26% | +134,900 | New | +$24.9M |
|
23
BioMarin Pharmaceuticals
BMRN
$11.2B
| $22.2M | 1.12% | +162,500 | New | +$22.2M |
|
|
SGNT
24
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $22.2M | 1.12% | +912,381 | New | +$22.2M |
|
25
DexCom
DXCM
$29.5B
| $21.4M | 1.08% | +267,500 | New | +$21.4M |
|